184 related articles for article (PubMed ID: 37448274)
1. [Clinical and laboratory characteristics of arginine vasopressin resistance, caused by a new homozygous mutation p.R113C in AQP2].
Makretskaya NA; Nanzanova US; Hamaganova IR; Eremina ER; Tiulpakov AN
Probl Endokrinol (Mosk); 2023 May; 69(2):75-79. PubMed ID: 37448274
[TBL] [Abstract][Full Text] [Related]
2. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
Bichet DG; Bockenhauer D
Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
[TBL] [Abstract][Full Text] [Related]
3. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
Gao C; Higgins PJ; Zhang W
Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
[TBL] [Abstract][Full Text] [Related]
4. Nephrogenic diabetes insipidus.
Bichet DG
Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.
Vargas-Poussou R; Forestier L; Dautzenberg MD; Niaudet P; Déchaux M; Antignac C
J Am Soc Nephrol; 1997 Dec; 8(12):1855-62. PubMed ID: 9402087
[TBL] [Abstract][Full Text] [Related]
6. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
Devuyst O
Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
[TBL] [Abstract][Full Text] [Related]
7. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
[TBL] [Abstract][Full Text] [Related]
8. Novel mutation of aquaporin-2 gene in a patient with congenital nephrogenic diabetes insipidus.
Moon SS; Kim HJ; Choi YK; Seo HA; Jeon JH; Lee JE; Lee JY; Kwon TH; Kim JG; Kim BW; Lee IK
Endocr J; 2009; 56(7):905-10. PubMed ID: 19461158
[TBL] [Abstract][Full Text] [Related]
9. Two novel mutations in the aquaporin 2 gene in a girl with congenital nephrogenic diabetes insipidus.
Cheong HI; Cho SJ; Zheng SH; Cho HY; Ha IS; Choi Y
J Korean Med Sci; 2005 Dec; 20(6):1076-8. PubMed ID: 16361827
[TBL] [Abstract][Full Text] [Related]
10. V2R mutations and nephrogenic diabetes insipidus.
Bichet DG
Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
[TBL] [Abstract][Full Text] [Related]
11. Nephrogenic diabetes insipidus.
Bichet DG
Am J Med; 1998 Nov; 105(5):431-42. PubMed ID: 9831428
[TBL] [Abstract][Full Text] [Related]
12. Severe congenital nephrogenic diabetes insipidus in a compound heterozygote with a new large deletion of the AQP2 gene. A case report.
Peces R; Mena R; Peces C; Santos-Simarro F; Fernández L; Afonso S; Lapunzina P; Selgas R; Nevado J
Mol Genet Genomic Med; 2019 Apr; 7(4):e00568. PubMed ID: 30784238
[TBL] [Abstract][Full Text] [Related]
13. A female with X-linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature.
Ding C; Beetz R; Rittner G; Bartsch O
Am J Med Genet A; 2020 May; 182(5):1032-1040. PubMed ID: 32073219
[TBL] [Abstract][Full Text] [Related]
14. Genetic basis of nephrogenic diabetes insipidus.
Hureaux M; Vargas-Poussou R
Mol Cell Endocrinol; 2023 Jan; 560():111825. PubMed ID: 36460218
[TBL] [Abstract][Full Text] [Related]
15. Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.
Sasaki S; Chiga M; Kikuchi E; Rai T; Uchida S
Clin Exp Nephrol; 2013 Jun; 17(3):338-44. PubMed ID: 23150186
[TBL] [Abstract][Full Text] [Related]
16. A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation.
Zang L; Gong Y; Li Y; Dou J; Lyu Z; Su X; Zhang Y; Mu Y
Biomed Res Int; 2022; 2022():7073158. PubMed ID: 35865667
[TBL] [Abstract][Full Text] [Related]
17. Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.
Moeller HB; Rittig S; Fenton RA
Endocr Rev; 2013 Apr; 34(2):278-301. PubMed ID: 23360744
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin-aquaporin-2 pathway: recent advances in understanding water balance disorders.
Ranieri M; Di Mise A; Tamma G; Valenti G
F1000Res; 2019; 8():. PubMed ID: 30800291
[TBL] [Abstract][Full Text] [Related]
19. [Nephrogenic diabetes insipidus].
Bichet DG
Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic diabetes insipidus.
Morello JP; Bichet DG
Annu Rev Physiol; 2001; 63():607-30. PubMed ID: 11181969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
